RE: Woodford13 Jan 2020 14:04
MREO / Mereo BioPharma Group plc 6-K - Current Report of Foreign Issuer - 6-K
12m sec.gov
6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 or 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of January, 2020 Commission File Number: 001-38452 MEREO BIOPHARMA GROUP PLC (Translation of registrant?s name into English) 4th Floor, One Cavendish Place, London, W1G 0QF, United Kingdom (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
MREO